This inventor holds 4 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Chroma Therapeutics Limited, Glaxosmithkline Intellectual Property Development Limited. Active years: 2011-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 19 
1 out of 242 
Years Active: 2011-2015
Title: Alistair David Graham Donald: Innovator in Histone Deacetylase Inhibitors
Introduction
Alistair David Graham Donald is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that serve as inhibitors of histone deacetylase. With a total of four patents to his name, his work is pivotal in the treatment of cell proliferative diseases, including various forms of cancer.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Hydroxamates as inhibitors of histone deacetylase." This patent details compounds of a specific formula that are effective in inhibiting histone deacetylase activity. These compounds are particularly useful in treating cancers, showcasing the potential for significant advancements in cancer therapy. The patent outlines the structural components of these compounds, including various radicals and linkers that contribute to their efficacy.
Career Highlights
Throughout his career, Alistair has worked with prominent companies in the pharmaceutical sector. Notable among these are Chroma Therapeutics Limited and GlaxoSmithKline Intellectual Property Development Limited. His experience in these organizations has allowed him to refine his expertise in drug development and patenting innovative solutions for complex medical challenges.
Collaborations
Alistair has collaborated with esteemed colleagues, including Alan Hornsby Davidson and Sanjay Ratilal Patel. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective therapeutic agents.
Conclusion
Alistair David Graham Donald stands out as a significant figure in the realm of biochemistry and patent innovation. His contributions to the development of histone deacetylase inhibitors are crucial for advancing cancer treatment. His work exemplifies the impact of innovative thinking in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile